4.6 Article

Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials

Related references

Note: Only part of the references are listed.
Article Otorhinolaryngology

Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials

Austin L. Johnson et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Letter Medicine, General & Internal

Publication Rate and Characteristics of Lung Cancer Clinical Trials

Ghassan Al-Shbool et al.

JAMA NETWORK OPEN (2019)

Article Cardiac & Cardiovascular Systems

Discontinuation and non-publication of clinical trials in cardiovascular medicine

Alistair J. Roddick et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Multidisciplinary Sciences

Time to publication of oncology trials and why some trials are never published

Paul B. Chapman et al.

PLOS ONE (2017)

Review Medicine, Research & Experimental

Association of the FDA Amendment Act with trial registration, publication, and outcome reporting

Adam T. Phillips et al.

TRIALS (2017)

Article Oncology

Publication status of contemporary oncology randomised controlled trials worldwide

Yu-Pei Chen et al.

EUROPEAN JOURNAL OF CANCER (2016)

Article Medicine, General & Internal

Selective publication of antidepressant trials and its influence on apparent efficacy

Erick H. Turner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medicine, General & Internal

Factors associated with failure to publish large randomized trials presented at an oncology meeting

MK Krzyzanowska et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)